Shortly after Anja Busse was diagnosed with Type 1 diabetes, the 11-year-old reached out to Mattel, the parent company of the American Girl dolls, with an idea.
Even as the White House touts the Affordable Care Act's successful coverage of nearly 20 million people, residents across the country are struggling to access and afford healthcare and social service programs.
David Dunlap, president and CEO of Roper St. Francis, announced he's retiring at the end of the year.
The technology uses an ingestible sensor, a wearable patch and a software application to track medication adherence.
This year, University of Illinois Hospital & Health Sciences System and partners are testing a program to reduce these costs. It is modeled on a strategy known as “Housing First” that is catching on across the country.
Ann Arbor, Mich.-based Hygieia, a medical device company, has teamed up with Blue Cross and Blue Shield of Michigan to launch a demonstration project to help about 1,000 diabetic patients more effectively manage their disease.
The CMS' decision this week to pay for the Diabetes Prevention Program is long overdue since its success in reducing obesity and thereby diabetes risk has been well documented in the medical and healthcare economics literature, and covered by certain sections of the press—like us.
An improving investment picture and innovative benefit programs have brightened the financial picture for the $61 billion UAW Retiree Medical Benefits Trust.
Participants lost weight and learned about healthy living while Medicare saved enough money per person to pay for the program and then some. HHS hopes the program's success will inspire employers and insurers to develop their own wellness programs. Experts say history shows they might.
While a new study shows the dementia incident rate has dropped 20% each decade on average since the 1970s, the actual reasons for the decline aren't fully understood. Preventive factors, such as improvements in cardiovascular health and early detection may have played a role.
Medical manufacturing giant Johnson & Johnson has announced plans to restructure its medical-device businesses after several quarters of declining sales. Johnson & Johnson says it will use the money it saves to fund investments in “new growth opportunities” and new products in the...
One of the nation's leading endocrinologists warns that a so-called "artificial pancreas" touted as a game-changer for the treatment of diabetes could also bring headaches to the industry as it learns how to get reimbursed for advice given in between visits.